Author | Vanessa Caceres

Articles

Another Study Shows No Malignancy after Biologics

September 06, 2016

Article

Rheumatoid arthritis patients who have had a malignancy and are receiving a TNFi or rituximab (RTX), do not appear to have an increased risk of cancer recurrence.

Tofacitinib Ranks High in Patient-Reported Outcomes

September 06, 2016

Article

Brief report in the journal Arthritis Care and Research shows that patients report favorable outcomes with a tofacitinib/DMARD combo therapy.

Screening is Lax in Glucocorticoid-Induced Osteoporosis

July 11, 2016

Article

Some patients are not being screened or treated for glucocorticoid-induced osteoporosis by primary care physicians or rheumatologists.

Treg Cells Implicated in JIA

June 23, 2016

Article

Treg cells are more prevalent in patients with juvenile idiopathic arthritis and active inflammation, as compared to patients in remission.